Latest Safety News

AGL Energy reported a 575% surge in statutory profit to $756 million for FY26, driven by strategic divestments and improved asset flexibility, while declaring a fully franked 50 cents dividend and progressing its energy transition with 12 GW of renewable capacity targeted by 2035.

Black Horse Mining Limited completed an $8 million IPO and acquired an 80% stake in the Mt Egerton Gold Project holder. The company reported a $5.87 million loss for FY26, driven by exploration costs and significant share-based payments.

Chrysos Corporation posted a 33% revenue increase and 68% EBITDA growth in FY26, driven by expanding its PhotonAssay™ technology fleet to 46 units worldwide and signing 24 new lease agreements.

Newmont and Barrick have settled all disputes related to their Nevada Gold Mines joint venture, agreeing to contribute previously excluded properties and updating governance terms. Newmont will pay Barrick $1.95 billion, while also consenting to Barrick's proposed North American gold assets IPO.

Life360 has surged past 100 million monthly active users, posting record revenue and subscriber growth in Q2 2026. Its AI-driven platform and expanding advertising business underpin strong profitability and a confident outlook.

SGH Ltd (ASX:SGH) reported a 1% rise in underlying EBIT to $1.55 billion for FY26, driven by margin gains at Boral and WesTrac, alongside a disciplined capital allocation strategy including a $500 million on-market buy-back.

PGG Wrightson posted a robust FY26 with $1.1 billion revenue and a 46% jump in net profit, driven by strong livestock prices and strategic acquisitions.

CleanSpace has secured its largest-ever industrial order, worth approximately A$1.9 million, from a global mining customer operating in Indonesia, signalling growing confidence in its respiratory protection technology.

Talius has secured a substantial $850,000 purchase order from New Zealand’s Hato Hone St John, adding 8,000 devices and boosting its recurring revenue by $55,000 annually.

Percheron Therapeutics announces Dr Michael Baker as incoming CEO, replacing Dr James Garner who steps down after three years. Baker’s appointment aligns executive incentives with shareholder value as the company prepares for a pivotal HMBD-002 clinical trial.

EVE Health Group has progressed its Libbo pilot clinical study for erectile dysfunction with dosing set for Q4 2026 and achieved a major solubility breakthrough for apixaban, while appointing Ben Rohr as CEO to drive commercial growth.

RocketDNA Ltd has secured a $1 million contract extension from BHP Mitsubishi Alliance to continue its autonomous drone operations in the Bowen Basin until October 2026, reinforcing its position in mining tech.